• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HO 触发的“开/关信号”纳米颗粒针对 P-选择素,用于非侵入性和对比增强的动脉血栓形成治疗诊断。

HO-triggered "off/on signal" nanoparticles target P-selectin for the non-invasive and contrast-enhanced theranostics for arterial thrombosis.

机构信息

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China; School of Pharmacy, Chengdu University, Chengdu, 610106, China.

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.

出版信息

Acta Biomater. 2023 Mar 1;158:769-781. doi: 10.1016/j.actbio.2022.12.026. Epub 2022 Dec 21.

DOI:10.1016/j.actbio.2022.12.026
PMID:36565786
Abstract

Pathological coagulation within an injured artery and the subsequent cardiovascular complications, such as stroke and heart attack, greatly threaten human life. Inspired by the biochemical features of acute arterial thrombosis, such as abundant activated platelets and hydrogen peroxide (HO), we constructed platelet-targeted theranostic nanoparticles (CyBA/PFM NPs) with HO-triggered photoacoustic contrast enhancement and antithrombotic capabilities. CyBA/PFM NPs were designed to target platelet-rich clots via fucoidan segment within the carrier, which could be activated by HO to produce fluorescent "CyOH" molecules, thus turning on the photoacoustic signal. CyBA/PFM NPs showed obvious amplification of fluorescence following incubation with fresh clots, exhibiting efficient scavenging ability of intracellular reactive oxygen species (ROS). In a FeCl-induced mouse model of carotid thrombosis, CyBA/PFM NPs significantly amplified the photoacoustic contrast in thrombogenic tissues, effectively eliminated ROS within the occlusion site, and suppressed the thrombus formation, accompanied by a normalization of the soluble CD40L level. Given their accurate imaging potential, potent antithrombotic activities and acceptable biosafety, CyBA/PFM NPs hold strong potential as nanoscale theranostics for HO-correlated cardiovascular diseases. STATEMENT OF SIGNIFICANCE: In this study, we developed a platelet-targeted and HO-triggered nanosystem self-assembled from phenylboronated fucoidan/maltodextrin polymers and responsive near-infrared probes. The fucoidan segment within the carrier could facilitate the specific delivery of the therapeutic polymers and probes to the platelet-rich arterial thrombus. In a mouse model of FeCl-induced arterial thrombosis, the system could be activated by HO to produce fluorescent "CyOH" molecules, thus turning on the photoacoustic signal and specifically imaging thrombosed tissues. Besides, CyBA/PFM NPs significantly effectively eliminated ROS within the occlusion site and suppressed the thrombus formation. Given their theranostic potential and acceptable biosafety, this system has great potential for HO-correlated cardiovascular diseases.

摘要

损伤动脉内的病理性凝血以及随后的心血管并发症,如中风和心脏病发作,极大地威胁着人类的生命。受急性动脉血栓形成的生化特征的启发,如丰富的活化血小板和过氧化氢 (HO),我们构建了具有 HO 触发光声对比增强和抗血栓能力的血小板靶向治疗纳米颗粒 (CyBA/PFM NPs)。CyBA/PFM NPs 被设计通过载体中的褐藻糖胶片段靶向富含血小板的血栓,该片段可被 HO 激活以产生荧光“CyOH”分子,从而开启光声信号。CyBA/PFM NPs 在与新鲜血栓孵育后显示出明显的荧光放大,表现出对细胞内活性氧物种 (ROS) 的有效清除能力。在 FeCl 诱导的颈动脉血栓形成小鼠模型中,CyBA/PFM NPs 显著放大了血栓组织中的光声对比,有效消除了闭塞部位的 ROS,并抑制了血栓形成,同时使可溶性 CD40L 水平正常化。鉴于其准确的成像潜力、强大的抗血栓活性和可接受的生物安全性,CyBA/PFM NPs 作为与 HO 相关的心血管疾病的纳米级治疗学具有很大的潜力。

意义声明

在这项研究中,我们开发了一种由苯硼酸化褐藻糖胶/麦芽糊精聚合物和响应性近红外探针自组装而成的血小板靶向和 HO 触发纳米系统。载体中的褐藻糖胶片段有助于将治疗聚合物和探针特异性递送至富含血小板的动脉血栓。在 FeCl 诱导的动脉血栓形成小鼠模型中,该系统可被 HO 激活产生荧光“CyOH”分子,从而开启光声信号并特异性成像血栓组织。此外,CyBA/PFM NPs 可显著有效消除闭塞部位的 ROS 并抑制血栓形成。鉴于其治疗学潜力和可接受的生物安全性,该系统在与 HO 相关的心血管疾病方面具有巨大的潜力。

相似文献

1
HO-triggered "off/on signal" nanoparticles target P-selectin for the non-invasive and contrast-enhanced theranostics for arterial thrombosis.HO 触发的“开/关信号”纳米颗粒针对 P-选择素,用于非侵入性和对比增强的动脉血栓形成治疗诊断。
Acta Biomater. 2023 Mar 1;158:769-781. doi: 10.1016/j.actbio.2022.12.026. Epub 2022 Dec 21.
2
Fibrin-Targeted and HO-Responsive Nanoparticles as a Theranostics for Thrombosed Vessels.纤维蛋白靶向和 HO 响应性纳米粒子作为血栓血管的治疗诊断一体化。
ACS Nano. 2017 Jun 27;11(6):6194-6203. doi: 10.1021/acsnano.7b02308. Epub 2017 May 18.
3
Molecularly Engineered Theranostic Nanoparticles for Thrombosed Vessels: HO-Activatable Contrast-Enhanced Photoacoustic Imaging and Antithrombotic Therapy.用于血栓血管的分子工程化治疗性纳米颗粒:HO 激活型对比增强光声成像和抗血栓治疗。
ACS Nano. 2018 Jan 23;12(1):392-401. doi: 10.1021/acsnano.7b06560. Epub 2018 Jan 2.
4
Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.用于溶栓药物、藻源抗凝剂和近红外荧光对比剂共递送的血栓靶向治疗性纳米复合材料。
Acta Biomater. 2021 Oct 15;134:686-701. doi: 10.1016/j.actbio.2021.07.072. Epub 2021 Aug 3.
5
Hydrogen peroxide-responsive platelet membrane-coated nanoparticles for thrombus therapy.基于血小板膜的过氧化氢响应性纳米颗粒用于血栓治疗。
Biomater Sci. 2021 Apr 7;9(7):2696-2708. doi: 10.1039/d0bm02125c. Epub 2021 Feb 22.
6
Nanoassemblies of Self-Immolative Boronate-Bridged Retinoic Acid Dimeric Prodrug as a Clot-Targeted Self-Deliverable Antithrombotic Nanomedicine.自毁型硼桥接维甲酸二聚体前药纳米组装体作为一种血栓靶向自递送抗血栓纳米药物。
ACS Nano. 2023 Jul 11;17(13):12336-12346. doi: 10.1021/acsnano.3c01503. Epub 2023 Jun 29.
7
Stimulus-activatable echogenic maltodextrin nanoparticles as nanotheranostic agents for peripheral arterial disease.刺激响应性声敏麦芽糊精纳米粒作为周围动脉疾病的诊疗一体化纳米载体。
Biomaterials. 2019 Feb;192:282-291. doi: 10.1016/j.biomaterials.2018.11.022. Epub 2018 Nov 14.
8
H2O2-triggered bubble generating antioxidant polymeric nanoparticles as ischemia/reperfusion targeted nanotheranostics.H2O2触发的产生气泡的抗氧化聚合物纳米颗粒作为缺血/再灌注靶向纳米诊疗剂
Biomaterials. 2016 Apr;85:195-203. doi: 10.1016/j.biomaterials.2016.01.070. Epub 2016 Feb 2.
9
Functionalized polymeric hybrid micelles as an efficient nanotheranostic agent for thrombus imaging and thrombolysis.功能化聚合物杂化胶束作为一种用于血栓成像和溶栓的高效纳米诊疗剂。
Acta Biomater. 2021 Mar 1;122:278-290. doi: 10.1016/j.actbio.2020.10.015. Epub 2020 Dec 25.
10
Ultrasound imaging and on-demand therapy of peripheral arterial diseases using HO-Activated bubble generating anti-inflammatory polymer particles.超声成像及按需治疗外周动脉疾病使用 HO-激活泡生成抗炎聚合物粒子。
Biomaterials. 2018 Oct;179:175-185. doi: 10.1016/j.biomaterials.2018.07.003. Epub 2018 Jul 2.

引用本文的文献

1
Multiscale physics-based modelling of nanocarrier-assisted intravascular drug delivery.基于多尺度物理的纳米载体辅助血管内药物递送建模
Front Drug Deliv. 2024 Mar 4;4:1362660. doi: 10.3389/fddev.2024.1362660. eCollection 2024.
2
AG86 Peptide-modified Reactive Oxygen Species-responsive Polymer Nanovesicles for Transdermal Delivery of Hydrophilic Ergothioneine to Basal Keratinocytes.用于将亲水性麦角硫因经皮递送至基底角质形成细胞的AG86肽修饰的活性氧响应性聚合物纳米囊泡。
AAPS PharmSciTech. 2025 May 9;26(5):128. doi: 10.1208/s12249-025-03122-7.
3
Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics.
用于血栓诊断和治疗的纳米颗粒:血栓治疗学中的新兴趋势。
Nanotheranostics. 2024 Jan 1;8(2):127-149. doi: 10.7150/ntno.92184. eCollection 2024.
4
Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy.基于血小板的刺激响应型纳米粒子用于抗肿瘤治疗。
Int J Nanomedicine. 2023 Nov 6;18:6293-6309. doi: 10.2147/IJN.S436373. eCollection 2023.